- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Risk of Breast Cancer in France
Total 1647 results
-
Centre Francois BaclesseSanofi; National Cancer Institute, FranceCompleted
-
Institut Cancerologie de l'OuestRecruiting
-
Centre Georges Francois LeclercRecruiting
-
University Hospital, BrestTyco Healthcare GroupCompleted
-
UNICANCERNational Cancer Institute, FranceRecruitingBreast Cancer | DCIS | Low Risk DCIS | Breast Conserving Surgery | Radiotherapy OmissionFrance
-
Centre Hospitalier Universitaire de BesanconUnknownBreast Cancer | Colorectal Cancer | Lung CancerFrance
-
Jules Bordet InstituteHoffmann-La RocheActive, not recruitingHER2-negative Breast Cancer | ER+ Breast Cancer | Invasive Lobular Breast CarcinomaFrance, Belgium
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
Institut du Cancer de Montpellier - Val d'AurelleNot yet recruiting
-
University Hospital, ToulouseRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
University Hospital, RouenCompletedFetal Growth Retardation | High-Risk PregnancyFrance
-
University Hospital, MontpellierUniversity Hospital, Brest; University Hospital, Lille; University Hospital Saint... and other collaboratorsCompleted
-
Central Hospital, Nancy, FranceRecruitingStudy of Risk Factors for IPMNs Degeneration at the Nancy CHRUFrance
-
UNICANCERGilead SciencesRecruitingMetastatic Breast Cancer | Triple Negative Breast CancerFrance
-
University of LorraineLigue contre le cancer, FranceRecruitingQuality of Life | Cancer, Breast | Resilience, Psychological | Adverse Childhood Experiences | Attachment Styles | Epigenesis, GeneticFrance
-
Institut de cancérologie Strasbourg EuropeCentre de recherche du Centre hospitalier universitaire de SherbrookeRecruitingTriple-negative Breast CancerFrance
-
GWT-TUD GmbHAmsterdam UMC, location VUmc; BerGenBio ASA; Groupe Francophone des MyelodysplasiesCompletedAcute Myeloid Leukemia | High-risk Myelodysplastic Syndrome | Low-risk Myelodysplastic SyndromeGermany, Netherlands, France
-
Case Comprehensive Cancer CenterTerminatedBreast Cancer | Colorectal Cancer | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisAstraZenecaRecruitingEarly Small (cT1N0) Triple Negative Breast CancerFrance
-
Institut du Cancer de Montpellier - Val d'AurelleRecruiting
-
University Hospital, AngersCompletedto Elaborate a New Simple Clinical Tool for the Risk of Falls Among Older Inpatients.France
-
Centre Leon BerardJanssen, LP; Fondation ARCRecruitingMetastatic Breast CancerFrance
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.RecruitingMetastatic Breast CancerFrance
-
Centre Henri BecquerelCompleted
-
Quanta MedicalLattice MedicalRecruitingBreast Reconstruction | Breast Cancer Female | Breast Cancer PreventGeorgia, France
-
Centre Oscar LambretLaboratoire PRISM - Michel SALZETRecruitingAdvanced Breast CancerFrance
-
Institut Paoli-CalmettesRecruitingBreast Cancer FemaleFrance
-
Centre Antoine LacassagneActive, not recruitingLocalized Breast CancerFrance
-
University Hospital, MontpellierCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedMetastatic Breast CancerFrance
-
University Hospital, Strasbourg, FranceCompletedInfiltrative Breast CancerFrance
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance
-
Institut Claudius RegaudFondation Toulouse Cancer SantéRecruitingMetastatic Breast CancerFrance
-
Institut Paoli-CalmettesActive, not recruitingInvasive Breast CancerFrance
-
Hôpital Privé des Côtes d'Armor (HPCA)Completed
-
ARCAGY/ GINECO GROUPCompleted
-
Institut du Cancer de Montpellier - Val d'AurelleNot yet recruiting
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Institut CurieRecruitingHER2-negative Metastatic Breast CancerFrance
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
Institut Claudius RegaudCompletedTriple Negative Breast CancerFrance
-
Centre Jean PerrinTerminated
-
Centre Georges Francois LeclercSanofi; GlaxoSmithKlineCompletedMetastatic Breast CancerFrance
-
Centre Francois BaclesseUMR_S 1077 Inserm-EPHE-Normandie UniversitéRecruitingQuality of Life | Breast Cancer | SleepFrance
-
Centre Francois BaclesseRecruiting
-
Advaxis, Inc.Gynecologic Oncology GroupTerminatedHigh Risk Cervical Cancer | Advanced Cervical CancerUnited States, Argentina, Brazil, Canada, Chile, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Serbia, Spain, Taiwan, Ukraine
-
UNICANCERGlaxoSmithKlineCompletedMetastatic Breast Cancer | 70 Years Old Patients and Over | After One Line of Chemotherapy With TrastuzumabFrance
-
ARCAGY/ GINECO GROUPTerminatedFirst Line Metastatic Breast CancerFrance
-
Institut Paoli-CalmettesNovartis PharmaceuticalsRecruitingAdvanced or Metastatic Breast Cancer (BC)France